0001140361-18-008870.txt : 20180216 0001140361-18-008870.hdr.sgml : 20180216 20180216200124 ACCESSION NUMBER: 0001140361-18-008870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180214 FILED AS OF DATE: 20180216 DATE AS OF CHANGE: 20180216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAZELSKY JAY CENTRAL INDEX KEY: 0001556270 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 18622778 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2018-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001556270 MAZELSKY JAY ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President Common Stock 2018-02-14 4 M 0 544 0 A 19467 D Common Stock 2018-02-14 4 M 0 403 0 A 19870 D Common Stock 2018-02-14 4 M 0 472 0 A 20342 D Common Stock 2018-02-14 4 M 0 737 0 A 21079 D Common Stock 2018-02-14 4 M 0 459 0 A 21538 D Common Stock 2018-02-14 4 F 0 778 178.26 D 20760 D Non-Qualified Stock Option (right-to-buy) 178.26 2018-02-14 4 A 0 25140 A 2028-02-13 Common Stock 25140 25140 D Incentive Stock Option (right-to-buy) 178.26 2018-02-14 4 A 0 560 A 2028-02-13 Common Stock 560 560 D Restricted Stock Unit 2018-02-14 4 A 0 2524 A Common Stock 2524 11492 D Restricted Stock Unit 2018-02-14 4 M 0 544 D Common Stock 544 10948 D Restricted Stock Unit 2018-02-14 4 M 0 403 D Common Stock 403 10545 D Restricted Stock Unit 2018-02-14 4 M 0 472 D Common Stock 472 10073 D Restricted Stock Unit 2018-02-14 4 M 0 737 D Common Stock 737 9336 D Restricted Stock Unit 2018-02-14 4 M 0 459 D Common Stock 459 8877 D Includes 39 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 29, 2017. Closing price of Issuer's common stock on the NASDAQ market on February 14, 2018. Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2019. Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. No applicable. /s/ Lily J. Lu, Attorney-in-Fact for Jay Mazelsky 2018-02-16